BCG Polysaccharide and Nucleic Acid (Hunan Jiuzhitang-Siqi Biopharmaceutical)

卡介菌多糖核酸注射剂

Report date: 2023/11/01 11:28:10

Base Information

Drug NameBCG Polysaccharide and Nucleic Acid (Hunan Jiuzhitang-Siqi Biopharmaceutical)
Drug Alias Name斯奇康
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrticariaPsoriasisEczema +[5] 
Global Approved IndicationsUrticariaPsoriasisEczema +[5] 
Approved Indications in ChinaUrticariaPsoriasisEczema +[5] 
Original Approved Country/TerritoryMainland China
Original Approved Date2002/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHunan Jiuzhitang Siqi Biological Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Jiuzhitang Siqi Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUrticariaPsoriasisEczema +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AX03
Related LinksN/A